Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BioNTech News

xrp
Julian Parker 2026 Jul 08, 16:04

XRP Price Forecast 2026–2030: Can It Reach New Highs?

crypto
samsung
Julian Parker 2026 Jul 07, 16:01

Samsung Stock Price Forecast 2026–2030: AI Memory Cycle, HBM4 Expansion, and Market Structure

stocks
sk-hynix
Julian Parker 2026 Jul 06, 16:03

Why Is SK Hynix Stock Falling Before Its Nasdaq Listing?

stocks
Darius Anucauskas 2026 Jul 06, 16:03

KOSPI takes a beating, DXY awaits for the next moving data

stocks indices
sliver
Julian Parker 2026 Jul 05, 16:02

Silver Price Forecast: Weak US Jobs Data Lifts XAG/USD, but Risks Remain

commodity
trade
Julian Parker 2026 Jul 01, 16:02

What is a Good P/E Ratio? Formula, Meaning & Trading Guide

cfd trading
vix
Julian Parker 2026 Jun 30, 16:02

What Is the VIX Volatility Index? A Trader’s Guide to Market Fear

cfd trading
Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks

Latest news

Show more
softbank
Julian Parker 2026 Jul 09, 16:05

SoftBank Stock Surges 11% as OpenAI’s GPT-5.6 Revives AI Optimism

Stock
gold
Julian Parker 2026 Jul 09, 16:04

Gold Price Holds Above $4,100 as Weaker Dollar Offsets Fed Rate Hike Risks

gold price today
us-Iran-oil
Julian Parker 2026 Jul 09, 16:02

Brent Oil Price Heads for 6% Weekly Gain as Hormuz Risk Supports Crude

Commodities
dollar
Julian Parker 2026 Jul 08, 16:05

US Dollar Struggles Near 101 as Middle East Tensions Escalate and Traders Await US Data

Forex
gold
Julian Parker 2026 Jul 08, 16:04

Gold Price Today, July 9: XAU/USD Slides Toward $4,000 as Iran Shock Lifts Fed Rate-Hike Bets

gold price today
sk-hynix
Julian Parker 2026 Jul 08, 16:03

SK Hynix Shares Jump as U.S. ADR Listing Sees Heavy Demand

stocks
crypto
Julian Parker 2026 Jul 08, 16:03

Bitcoin Price Holds Near $62K as Oil, Fed and Strategy Risks Weigh

Cryptocurrencies
sliver
Julian Parker 2026 Jul 08, 16:02

Silver Price Rebounds Above $58 as Inflation Fears Keep Fed-Hike Bets Alive

Commodities

Info

Spread

1.2083

Spread (%)

1.3070 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

23513178112

Shares Outstanding

252884261

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-5.74

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
cfd-trading
Julian Parker 2026 Jul 09, 16:05

10 Best CFD Demo Accounts in the UAE

cfd-trading
Julian Parker 2026 Jul 09, 16:04

10 Best CFD Brokers for Beginners in the UAE 2026

cfd-trading
Julian Parker 2026 Jul 09, 16:03

How to Choose a CFD Broker in the UAE

Trustpilot